Company news

Click here for Products

Company news

Latest News: Seeing Into Deep Tissue
04-13-2023

Published April 13, 2023. Stanford professor and Nirmidas co-founder, is interviewed by Nature Photonics to discuss the ......
Nirmidas Has Obtained 12-Month Shelf Life for MidaSpot® COVID-19 Antibody Combo Detection Kit
11-09-2021

To comply with regular shelf-life testing updates imposed by the FDA for MidaSpot® COVID-19 Antibody Combo Detection Ki......
Nirmidas Biotech Receives FDA Emergency Use Authorization for its COVID-19 Rapid Antibody Fingerstick Test
01-05-2021

Click Here for News on Businesswire Click Here for News on 360 DXLearn More about MidaSpot COVID-19 Antibody Combo Detec......
Nirmdas Has Developed High-Accuracy pGOLD™ Microarray Based High Throughput ELISA-like COVID-19 IgG/IgM/IgA Assay for Research Use Only
04-06-2020

Nirmidas Biotech Inc. announces the availability of pGOLD™ COVID-19 IgG/IgM or IgG/IgM/IgA Assay kits for simultaneous,......
Nirmidas & StartX Team Up COVID-19 Task-force
03-19-2020

“Rapid tests initially being launched to clinical diagnostics labs and healthcare workers for point-of-care-testing. Th......
Nirmidas Launches DeepVision™ – the First NIR-II/SWIR Small Animal Imaging System in the US for Global Distribution
01-20-2020

Nirmidas is excited to announce the launching of a cutting-edge new product line: the DeepVision™ NIR-II/SWIR Small Ani......
Nirmidas Lays Groundwork For In-Vitro Diagnostic Products With pGOLD™ Slides Registered Under CE Mark
08-16-2019

“This is only the beginning of building our portfolios for CE-marked IVD products“ says CEO Meijie Tang. “pGOLD™ sli......
Nirmidas Biotech joins MedTech Outlook’s Top 10 In-Vitro Diagnostic Technology Solution Providers 2019
07-19-2019

Read full feature article here.
Nirmidas reaches a five-year product and service agreement with a CLIA lab to provide plasmonic pGOLD™ based diagnostic tests
11-21-2018

On October 24th, 2018 Nirmidas reached a 5-year Product and Service Agreement with a LDT lab of a major healthcare provi......
Nirmidas Launches New NIR-I-II-azide Dye
12-16-2017

NIRMIDAS IS PLEASED TO ANNOUNCE OUR NEW, NIR-I-II (IR-12N3) DYE:For both NIR-I and NIR-II fluorescence imagining in 800-......

Next Page Last Page

Company news

Latest News: Seeing Into Deep Tissue

04-13-2023

Published April 13, 2023. Stanford professor and Nirmidas co-founder, is interviewed by Nature Photonics to discuss the ......

Nirmidas Has Obtained 12-Month Shelf Life for MidaSpot® COVID-19 Antibody Combo Detection Kit

11-09-2021

To comply with regular shelf-life testing updates imposed by the FDA for MidaSpot® COVID-19 Antibody Combo Detection Ki......

Nirmidas Biotech Receives FDA Emergency Use Authorization for its COVID-19 Rapid Antibody Fingerstick Test

01-05-2021

Click Here for News on Businesswire Click Here for News on 360 DXLearn More about MidaSpot COVID-19 Antibody Combo Detec......

Nirmdas Has Developed High-Accuracy pGOLD™ Microarray Based High Throughput ELISA-like COVID-19 IgG/IgM/IgA Assay for Research Use Only

04-06-2020

Nirmidas Biotech Inc. announces the availability of pGOLD™ COVID-19 IgG/IgM or IgG/IgM/IgA Assay kits for simultaneous,......

Nirmidas & StartX Team Up COVID-19 Task-force

03-19-2020

“Rapid tests initially being launched to clinical diagnostics labs and healthcare workers for point-of-care-testing. Th......

Nirmidas Launches DeepVision™ – the First NIR-II/SWIR Small Animal Imaging System in the US for Global Distribution

01-20-2020

Nirmidas is excited to announce the launching of a cutting-edge new product line: the DeepVision™ NIR-II/SWIR Small Ani......

Nirmidas Lays Groundwork For In-Vitro Diagnostic Products With pGOLD™ Slides Registered Under CE Mark

08-16-2019

“This is only the beginning of building our portfolios for CE-marked IVD products“ says CEO Meijie Tang. “pGOLD™ sli......

Nirmidas Biotech joins MedTech Outlook’s Top 10 In-Vitro Diagnostic Technology Solution Providers 2019

07-19-2019

Read full feature article here.

Nirmidas reaches a five-year product and service agreement with a CLIA lab to provide plasmonic pGOLD™ based diagnostic tests

11-21-2018

On October 24th, 2018 Nirmidas reached a 5-year Product and Service Agreement with a LDT lab of a major healthcare provi......

Nirmidas Launches New NIR-I-II-azide Dye

12-16-2017

NIRMIDAS IS PLEASED TO ANNOUNCE OUR NEW, NIR-I-II (IR-12N3) DYE:For both NIR-I and NIR-II fluorescence imagining in 800-......

Contact us

For General Inquiries Email: info@nirmidas.com
For Product Support Email: support@nirmidas.com

Address

Nirmidas Biotech, Inc.
319 N. Bernardo Ave
Mountain View, CA, 94043, USA

Company news

Latest News: Seeing Into Deep Tissue

04-13-2023

Published April 13, 2023. Stanford professor and Nirmidas co-founder, is interviewed by Nature Photonics to discuss the ......

Nirmidas Has Obtained 12-Month Shelf Life for MidaSpot® COVID-19 Antibody Combo Detection Kit

11-09-2021

To comply with regular shelf-life testing updates imposed by the FDA for MidaSpot® COVID-19 Antibody Combo Detection Ki......

Nirmidas Biotech Receives FDA Emergency Use Authorization for its COVID-19 Rapid Antibody Fingerstick Test

01-05-2021

Click Here for News on Businesswire Click Here for News on 360 DXLearn More about MidaSpot COVID-19 Antibody Combo Detec......

Nirmdas Has Developed High-Accuracy pGOLD™ Microarray Based High Throughput ELISA-like COVID-19 IgG/IgM/IgA Assay for Research Use Only

04-06-2020

Nirmidas Biotech Inc. announces the availability of pGOLD™ COVID-19 IgG/IgM or IgG/IgM/IgA Assay kits for simultaneous,......

Nirmidas & StartX Team Up COVID-19 Task-force

03-19-2020

“Rapid tests initially being launched to clinical diagnostics labs and healthcare workers for point-of-care-testing. Th......

Nirmidas Launches DeepVision™ – the First NIR-II/SWIR Small Animal Imaging System in the US for Global Distribution

01-20-2020

Nirmidas is excited to announce the launching of a cutting-edge new product line: the DeepVision™ NIR-II/SWIR Small Ani......

Nirmidas Lays Groundwork For In-Vitro Diagnostic Products With pGOLD™ Slides Registered Under CE Mark

08-16-2019

“This is only the beginning of building our portfolios for CE-marked IVD products“ says CEO Meijie Tang. “pGOLD™ sli......

Nirmidas Biotech joins MedTech Outlook’s Top 10 In-Vitro Diagnostic Technology Solution Providers 2019

07-19-2019

Read full feature article here.

Nirmidas reaches a five-year product and service agreement with a CLIA lab to provide plasmonic pGOLD™ based diagnostic tests

11-21-2018

On October 24th, 2018 Nirmidas reached a 5-year Product and Service Agreement with a LDT lab of a major healthcare provi......

Nirmidas Launches New NIR-I-II-azide Dye

12-16-2017

NIRMIDAS IS PLEASED TO ANNOUNCE OUR NEW, NIR-I-II (IR-12N3) DYE:For both NIR-I and NIR-II fluorescence imagining in 800-......

Contact us

For General Inquiries Email: info@nirmidas.comFor Product Support Email: support@nirmidas.com

Address

Nirmidas Biotech, Inc.319 N. Bernardo AveMountain View, CA, 94043, USA

For General Inquiries Email: info@nirmidas.com
For Product Support Email: support@nirmidas.com

Nirmidas Biotech, Inc.
319 N. Bernardo Ave
Mountain View, CA, 94043, USA